In 2001, Peters et al. published a paper showing that ATF-7, a Novel bZIP Protein, interacts with PTP4A1. This ATF-7 is actually ATF5 and not ATF7, as noted by the authors at the end of their paper ("Note Added in Proof—While this manuscript was under review, sequences for mouse and human ATF-5 were deposited in GenBankTM. It appears that ATF-7 and ATF-5 are likely to be the same protein. In addition, an unrelated sequence named ATF7 has also been deposited in GenBankTM. In order to avoid confusion, future work on the protein described in this publication will likely refer to it as either ATF-5 or ATF-5/7.")
Olsen JV, Blagoev B, Gnad F, Macek B, Kumar C, Mortensen P, Mann M (2006). "Global, in vivo, and site-specific phosphorylation dynamics in signaling networks". Cell127 (3): 635–48. doi:10.1016/j.cell.2006.09.026. PMID17081983.
Hamard PJ, Dalbies-Tran R, Hauss C, Davidson I, Kedinger C, Chatton B (2005). "A functional interaction between ATF7 and TAF12 that is modulated by TAF4". Oncogene24 (21): 3472–83. doi:10.1038/sj.onc.1208565. PMID15735663.
Newman SP, Bates NP, Vernimmen D, Parker MG, Hurst HC (2000). "Cofactor competition between the ligand-bound oestrogen receptor and an intron 1 enhancer leads to oestrogen repression of ERBB2 expression in breast cancer". Oncogene19 (4): 490–7. doi:10.1038/sj.onc.1203416. PMID10698518.
Bocco JL, Bahr A, Goetz J, Hauss C, Kallunki T, Kedinger C, Chatton B (1996). "In vivo association of ATFa with JNK/SAP kinase activities". Oncogene12 (9): 1971–80. PMID8649858.
Pescini R, Kaszubska W, Whelan J, DeLamarter JF, Hooft van Huijsduijnen R (1994). "ATF-a0, a novel variant of the ATF/CREB transcription factor family, forms a dominant transcription inhibitor in ATF-a heterodimers". J. Biol. Chem.269 (2): 1159–65. PMID8288576.